Analysis of Cdx2 VDR gene polymorphism rs11568820 in association with multiple sclerosis in Slovaks.
Cdx-2 (rs11568820)
HLA-DRB1*15:01
Multiple sclerosis
disability progression
gene polymorphism
susceptibility
vitamin D receptor
Journal
Neurological research
ISSN: 1743-1328
Titre abrégé: Neurol Res
Pays: England
ID NLM: 7905298
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
medline:
8
9
2023
pubmed:
15
8
2023
entrez:
15
8
2023
Statut:
ppublish
Résumé
Vitamin D deficiency is involved in the pathogenesis of multiple sclerosis (MS), a severe autoimmune demyelinating disease of the central nervous system. The gene polymorphism Cdx-2 (rs11568820, G/A) seriously influences the trancriptional activity of the vitamin D receptor (VDR) that binds the vitamin D responsive elements of target genes including HLA-DRB1*15. The aim of the present study in Slovaks was to analyse the association of Cdx-2 variants with the risk of MS and disability progression, and to assess the DRB1*15:01 allele as a possible confounding factor. In total, 493 MS patients and 417 healthy controls were involved in this study. The genotyping of Cdx-2 was performed using restriction analysis; DRB1*15:01 positivity was determined by a high-resolution melting analysis of its surrogate marker rs3135388 (G/A). Our results did not prove any allelic association between Cdx-2 and a risk of MS (minor allele A - 0.181 in patients vs. 0.161 in controls, OR = 1.15, .95 CI = 0.90-1.47,
Identifiants
pubmed: 37581270
doi: 10.1080/01616412.2023.2247195
doi:
Substances chimiques
HLA-DRB1 Chains
0
VDR protein, human
0
Receptors, Calcitriol
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM